We Bring Research To You
Myeloproliferative neoplasms (MPNs) are a group of rare, chronic blood cancers in which excessive scar tissue is formed in the bone marrow causing the body to produce abnormal cells that replaces the normal blood cells. MPNs include Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia. More than 200,000 people in the U.S. are living with MPNs. Better medicine and treatment options are needed for MPNs in order to save thousands of people each year.
We believe patients like you are the key to making a difference in MPNs research. Joining a research study can help advance the future of MPNs research and impact the development of new treatments and cures.
Sanguine's unique model alleviates many of the difficulties associated with clinical trials and we make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel. Sign up to learn more and participate today!
Sanguine's Expertise in Accelerating Research
our community
member has participated
by Sanguine
our community
member has participated
by Sanguine
We are currently recruiting for 1 Myeloproliferative Neoplasms (MPNs) study
At-Home Myeloproliferative Neoplasms (MPN) Research Study
$50
Volunteers with myeloproliferative neoplasms (MPN) are needed to participate in a research study from the comfort of their own home. The main purpose of this study is to collect blood samples from volunteers to be used in various research studies at Incyte Corporation (Incyte) relating to myeloproliferative neoplasms (MPN), including genomic studies (i.e. how genes are different in people with MPNs). Your blood may assist researchers in developing a new treatment for MPN.
United States
Nationwide Partners
We partner with like-minded organizations and nonprofits to connect with patients who want to contribute and help accelerate research.
